Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

Ping Yu, Youjin Lee, Wenhua Liu, Thomas Krausz, Anita Chong, Hans Schreiber, Yang Xin Fu

Research output: Contribution to journalArticle

360 Citations (Scopus)

Abstract

Tumor environment can be critical for preventing the immunological destruction of antigenic tumors. We have observed a selective accumulation of CD4+CD25+ T cells inside tumors. In a murine fibrosarcoma Ld-expressing Ag104, these cells made up the majority of tumor-infiltrating lymphocytes at the late stage of tumor progression, and their depletion during the effector phase, rather than priming phase, successfully enhanced antitumor immunity. We show here that CD4+CD25+ T cells suppressed the proliferation and interferon-γ production of CD8+ T cells in vivo at the local tumor site. Blockade of the effects of IL-10 and TGF-β partially reversed the suppression imposed by the CD4+ cells. Furthermore, local depletion of CD4+ cells inside the tumor resulted in a change of cytokine milieu and led to the eradication of well-established highly aggressive tumors and the development of long-term antitumor memory. Therefore, CD4+CD25+ T cells maintained an environment in the tumor that concealed the immunogenicity of tumor cells to permit progressive growth of antigenic tumors. Our study illustrates that the suppression of antitumor immunity by regulatory T cells occurs predominantly at the tumor site, and that local reversal of suppression, even at a late stage of tumor development, can be an effective treatment for well-established cancers.

Original languageEnglish (US)
Pages (from-to)779-791
Number of pages13
JournalJournal of Experimental Medicine
Volume201
Issue number5
DOIs
StatePublished - Mar 7 2005

Fingerprint

Neoplasms
T-Lymphocytes
Rejection (Psychology)
Immunity
Tumor-Infiltrating Lymphocytes
Long-Term Memory
Fibrosarcoma
Regulatory T-Lymphocytes
Interleukin-10
Interferons
Cell Proliferation
Cytokines
Growth

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. / Yu, Ping; Lee, Youjin; Liu, Wenhua; Krausz, Thomas; Chong, Anita; Schreiber, Hans; Fu, Yang Xin.

In: Journal of Experimental Medicine, Vol. 201, No. 5, 07.03.2005, p. 779-791.

Research output: Contribution to journalArticle

Yu, Ping ; Lee, Youjin ; Liu, Wenhua ; Krausz, Thomas ; Chong, Anita ; Schreiber, Hans ; Fu, Yang Xin. / Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. In: Journal of Experimental Medicine. 2005 ; Vol. 201, No. 5. pp. 779-791.
@article{3ba57d85301644d2a319574eceba1a39,
title = "Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors",
abstract = "Tumor environment can be critical for preventing the immunological destruction of antigenic tumors. We have observed a selective accumulation of CD4+CD25+ T cells inside tumors. In a murine fibrosarcoma Ld-expressing Ag104, these cells made up the majority of tumor-infiltrating lymphocytes at the late stage of tumor progression, and their depletion during the effector phase, rather than priming phase, successfully enhanced antitumor immunity. We show here that CD4+CD25+ T cells suppressed the proliferation and interferon-γ production of CD8+ T cells in vivo at the local tumor site. Blockade of the effects of IL-10 and TGF-β partially reversed the suppression imposed by the CD4+ cells. Furthermore, local depletion of CD4+ cells inside the tumor resulted in a change of cytokine milieu and led to the eradication of well-established highly aggressive tumors and the development of long-term antitumor memory. Therefore, CD4+CD25+ T cells maintained an environment in the tumor that concealed the immunogenicity of tumor cells to permit progressive growth of antigenic tumors. Our study illustrates that the suppression of antitumor immunity by regulatory T cells occurs predominantly at the tumor site, and that local reversal of suppression, even at a late stage of tumor development, can be an effective treatment for well-established cancers.",
author = "Ping Yu and Youjin Lee and Wenhua Liu and Thomas Krausz and Anita Chong and Hans Schreiber and Fu, {Yang Xin}",
year = "2005",
month = "3",
day = "7",
doi = "10.1084/jem.20041684",
language = "English (US)",
volume = "201",
pages = "779--791",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "5",

}

TY - JOUR

T1 - Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

AU - Yu, Ping

AU - Lee, Youjin

AU - Liu, Wenhua

AU - Krausz, Thomas

AU - Chong, Anita

AU - Schreiber, Hans

AU - Fu, Yang Xin

PY - 2005/3/7

Y1 - 2005/3/7

N2 - Tumor environment can be critical for preventing the immunological destruction of antigenic tumors. We have observed a selective accumulation of CD4+CD25+ T cells inside tumors. In a murine fibrosarcoma Ld-expressing Ag104, these cells made up the majority of tumor-infiltrating lymphocytes at the late stage of tumor progression, and their depletion during the effector phase, rather than priming phase, successfully enhanced antitumor immunity. We show here that CD4+CD25+ T cells suppressed the proliferation and interferon-γ production of CD8+ T cells in vivo at the local tumor site. Blockade of the effects of IL-10 and TGF-β partially reversed the suppression imposed by the CD4+ cells. Furthermore, local depletion of CD4+ cells inside the tumor resulted in a change of cytokine milieu and led to the eradication of well-established highly aggressive tumors and the development of long-term antitumor memory. Therefore, CD4+CD25+ T cells maintained an environment in the tumor that concealed the immunogenicity of tumor cells to permit progressive growth of antigenic tumors. Our study illustrates that the suppression of antitumor immunity by regulatory T cells occurs predominantly at the tumor site, and that local reversal of suppression, even at a late stage of tumor development, can be an effective treatment for well-established cancers.

AB - Tumor environment can be critical for preventing the immunological destruction of antigenic tumors. We have observed a selective accumulation of CD4+CD25+ T cells inside tumors. In a murine fibrosarcoma Ld-expressing Ag104, these cells made up the majority of tumor-infiltrating lymphocytes at the late stage of tumor progression, and their depletion during the effector phase, rather than priming phase, successfully enhanced antitumor immunity. We show here that CD4+CD25+ T cells suppressed the proliferation and interferon-γ production of CD8+ T cells in vivo at the local tumor site. Blockade of the effects of IL-10 and TGF-β partially reversed the suppression imposed by the CD4+ cells. Furthermore, local depletion of CD4+ cells inside the tumor resulted in a change of cytokine milieu and led to the eradication of well-established highly aggressive tumors and the development of long-term antitumor memory. Therefore, CD4+CD25+ T cells maintained an environment in the tumor that concealed the immunogenicity of tumor cells to permit progressive growth of antigenic tumors. Our study illustrates that the suppression of antitumor immunity by regulatory T cells occurs predominantly at the tumor site, and that local reversal of suppression, even at a late stage of tumor development, can be an effective treatment for well-established cancers.

UR - http://www.scopus.com/inward/record.url?scp=15444377017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15444377017&partnerID=8YFLogxK

U2 - 10.1084/jem.20041684

DO - 10.1084/jem.20041684

M3 - Article

C2 - 15753211

AN - SCOPUS:15444377017

VL - 201

SP - 779

EP - 791

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 5

ER -